0001093557-20-000247.txt : 20200911 0001093557-20-000247.hdr.sgml : 20200911 20200911185732 ACCESSION NUMBER: 0001093557-20-000247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200909 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abbey Donald CENTRAL INDEX KEY: 0001534342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 201171940 MAIL ADDRESS: STREET 1: 3750 TORREY VIEW COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-09-09 0 0001093557 DEXCOM INC DXCM 0001534342 Abbey Donald 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP Quality and Regulatory Aff Common Stock 2020-09-09 4 S 0 5159 391.0 D 54782 D Common Stock 2020-09-09 4 S 0 1283 398.302 D 53499 D Common Stock 2020-09-09 4 S 0 3297 398.302 D 50202 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. Included in this number are 22,722 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. By: Jereme Sylvain For: Donald M Abbey 2020-09-11